Results 261 to 270 of about 160,408 (307)

IBD in 2013: enriching the therapeutic armamentarium for IBD.

Nature reviews. Gastroenterology & hepatology, 2014
In 2013, several new IBD drugs, including golimumab and vedolizumab, have been approved or completed successful programmes, showing efficacy in both Crohn’s disease and ulcerative colitis. In addition, classic IBD drugs have been formulated for colonic delivery, such as budesonide MMX®, which was recently approved for mild-to-moderate ulcerative ...
Danese S, Peyrin-Biroulet L
openaire   +2 more sources

IBD and genetics: new developments

Scandinavian Journal of Gastroenterology, 2003
Inflammatory bowel disease (IBD) is a complex disorder with an aetiology that is only partly understood. Apart from environmental factors, inheritance contributes to IBD.Family studies show an increased risk among family members of a patient with IBD, particularly among first-degree relatives.
Oostenbrug, L. E., van Dullemen, H. M., te Meerman, G. J., Jansen, P. L. M.   +3 more
openaire   +4 more sources

IBD: a family affair

Best Practice & Research Clinical Gastroenterology, 2004
The recent molecular advances in the understanding of the genetics of inflammatory bowel disease (IBD) have their grounding in studies examining IBD within different family groups and populations. The risk of IBD is highest in first-degree relatives of an IBD proband but more distant relatives are also at increased risk.
R K, Russell, J, Satsangi
openaire   +2 more sources

Overview of paediatric IBD

Seminars in Pediatric Surgery, 2017
Inflammatory bowel disease (IBD) is a chronic complex disease of children and adults requiring a range of medications and surgical techniques to induce and maintain remission. In common with other immune-mediated inflammatory disorders, it has shown an ever-increasing rise in incidence worldwide over the last 50 years.
David C, Wilson, Richard K, Russell
openaire   +2 more sources

Diverticulitis and IBD

Journal of Clinical Gastroenterology, 2004
Saraswathi, Nair, Mark, Peppercorn, Martin H, Floch, A Brian, West   +3 more
openaire   +2 more sources

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Gastroenterology, 2021
Bruce Sands, Jean Fred Colombel, Jasbir Dhaliwal   +2 more
exaly  

COVID-19 in IBD: The experience of a single tertiary IBD center

Digestive and Liver Disease, 2021
Paolo Gionchetti, Silvio Laureti, Fernando Rizzello   +2 more
exaly  

Inflammatory Bowel Diseases (IBD) and the Microbiome—Searching the Crime Scene for Clues

Gastroenterology, 2021
Eugene Chang
exaly  

The IBD-F Patient Self-Assessment Scale Accurately Depicts the Level of Fatigue and Predicts a Negative Effect on the Quality of Life of Patients With IBD in Clinical Remission

Inflammatory Bowel Diseases, 2021
George Kolios, Giorgos Bamias, Ioannis Koutsounas   +2 more
exaly  

IBD and pregnancy

Inflammatory Bowel Diseases, 2008
openaire   +2 more sources